Fig. 4From: Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm studyProgression-free survival (PFS) A Kaplan-Meier curve of PFS in the modified intent-to-treat population. B Kaplan-Meier curve of PFS in the triple-class refractory population. C Kaplan-Meier curve of PFS by best responseBack to article page